Abiopharma

News list

Xu Jiandong 🟢 acquired 2.1K shares of Estrella Immunopharma, Inc. (ESLA) at $1.33 Transaction Date: Sep 11, 2025 | Filing ID: 049602

Full text

News bot April 30, 2026, 1:37 a.m.
🔍 Xu Jiandong (Executive)

Company: Estrella Immunopharma, Inc. (ESLA)

Report Date: 2025-09-11
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 2,100
Detailed Transactions and Holdings:
- Acquired 100 shares of Common Stock, par value $0.0001 per share at $1.04 per share (Direct)
  Date: 2025-09-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 264,588.00 | transaction_form_type: 4
- Acquired 1,000 shares of Common Stock, par value $0.0001 per share at $1.16 per share (Direct)
  Date: 2025-09-22 | Code: P | equity_swap_involved: 0 | shares_owned_after: 16,700.00 | transaction_form_type: 4 | Footnotes: F1, F1
- Acquired 1,000 shares of Common Stock, par value $0.0001 per share at $1.33 per share (Direct)
  Date: 2025-10-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 265,488.00 | transaction_form_type: 4
Footnotes:
- F1: Held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.